ZFP106 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.691800E-01
Normal-vs-Stage2
1.492810E-01
Normal-vs-Stage3
1.660210E-01
Normal-vs-Stage4
8.194800E-01
Stage1-vs-Stage2
3.478200E-01
Stage1-vs-Stage3
6.410500E-02
Stage1-vs-Stage4
7.332800E-01
Stage2-vs-Stage3
3.984200E-03
Stage2-vs-Stage4
2.127000E-01
Stage3-vs-Stage4
1.135960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.261770E-01
Normal-vs-AfricanAmerican
6.925600E-01
Normal-vs-Asian
7.199700E-02
Caucasian-vs-AfricanAmerican
2.001800E-01
Caucasian-vs-Asian
2.315000E-01
AfricanAmerican-vs-Asian
1.062970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.134960E-01
Normal-vs-Female
1.829780E-01
Male-vs-Female
3.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.116400E-01
Normal-vs-Age(41-60Yrs)
3.786800E-01
Normal-vs-Age(61-80Yrs)
8.163700E-02
Normal-vs-Age(81-100Yrs)
3.244400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.490000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.733400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.058600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.664600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.100300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.479200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.234300E-02
Normal-vs-Daily Drinker
5.221400E-03
Normal-vs-Weekly Drinker
8.837800E-02
Normal-vs-Occasional Drinker
7.666300E-02
Normal-vs-Social Drinker
5.547800E-01
Non Drinker-vs-Daily Drinker
4.356000E-01
Non Drinker-vs-Weekly Drinker
6.373800E-01
Non Drinker-vs-Occasional Drinker
4.034800E-01
Non Drinker-vs-Social Drinker
1.160630E-01
Daily Drinker-vs-Weekly Drinker
2.373800E-01
Daily Drinker-vs-Occasional Drinker
1.022020E-01
Daily Drinker-vs-Social Drinker
4.999900E-02
Weekly Drinker-vs-Occasional Drinker
7.926800E-01
Weekly Drinker-vs-Social Drinker
2.413400E-01
Occasional Drinker-vs-Social Drinker
2.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.562600E-01
Normal-vs-Grade 2
2.908400E-01
Normal-vs-Grade 3
2.673200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.280400E-01
Grade 1-vs-Grade 3
7.419200E-01
Grade 1-vs-Grade 4
4.562600E-01
Grade 2-vs-Grade 3
5.592000E-01
Grade 2-vs-Grade 4
2.908400E-01
Grade 3-vs-Grade 4
2.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.179600E-02
Normal-vs-NonDiabetic
6.365600E-02
Diabetic-vs-NonDiabetic
8.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.543840E-01
Normal-vs-NoPancreatitis
6.638100E-02
Pancreatitis-vs-NoPancreatitis
6.861600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.249390E-01
Normal-vs-N1
1.553650E-01
N0-vs-N1
4.911800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.066850E-01
Normal-vs-TP53-NonMutant
4.483600E-01
TP53-Mutant-vs-TP53-NonMutant
8.217900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
